SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by De Paris, P.
Right arrow Articles by Caroldi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Paris, P.
Right arrow Articles by Caroldi, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In Vivo Inhibition of Serum Dopamine-β-Hydroxylase by CaNa2 EDTA injection

Paola De Paris

Istituto di Medicina del Lavoro, University of Padova, V.Facciolati 71, I-35127 Padova, Italy

Stefano Caroldi

Istituto di Medicina del Lavoro, University of Padova, V.Facciolati 71, I-35127 Padova, Italy

1 In humans CaNa 2EDTA increases urinary excretion of lead as well as that of essential metals such as zinc, ferrum and manganese but not that of copper.

2 We studied the effect of CaNa2EDTA injection on serum dopamine-β-hydroxylase, a copper-dependent enzyme, in three male lead welders hospitalized for suspected lead poisoning.

3 injection of CaNa 2EDTA (1000 mg i.v.) resulted in rapid reduction of serum dopamine-β-hydroxylase activity which returned to normal level within 24 hours.

4 Copper sulphate (8 µM) but not ethylmaleimide (10 mM) restored in vitro serum dopamine-β-hydroxylase activity to pre-dosing values which indicates that CaNa2EDTA inhibits dopamine-β-hydroxylase by removing copper from the enzyme.

5 An inverse dose effect relationship between injected CaNa2EDTA and residual serum dopamine-β-hydroxylase activity was observed.

6 In spite of the reported lack of changes in copper serum concentration, CaNa2EDTA significantly affects the activity of a copper-dependent enzyme in the serum.

7 As CaNa 2EDTA is currently the drug of choice for the treatment of asymptomatic lead poisoning in children, the effect of CaNa2EDTA on copper-enzymes requires further investigation.

Human & Experimental Toxicology, Vol. 13, No. 4, 253-256 (1994)
DOI: 10.1177/096032719401300405


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement